|1.||Zamboni, William C: 3 articles (08/2008 - 07/2005)|
|2.||Strychor, Sandra: 3 articles (08/2008 - 07/2005)|
|3.||Egorin, Merrill J: 3 articles (08/2008 - 07/2005)|
|4.||Eiseman, Julie L: 2 articles (08/2008 - 07/2005)|
|5.||Joseph, Erin: 2 articles (08/2008 - 07/2005)|
|6.||Parise, Robert A: 2 articles (08/2008 - 05/2006)|
|7.||Prijovich, Zeljko M: 2 articles (06/2007 - 10/2003)|
|8.||Roffler, Steve R: 2 articles (06/2007 - 10/2003)|
|9.||Leu, Yu-Lin: 2 articles (06/2007 - 10/2003)|
|10.||Chen, B-M: 2 articles (02/2007 - 05/2002)|
06/01/2006 - "Phase I trial of continuous infusion 9-aminocamptothecin in patients with advanced solid tumors: 21-day infusion is an active well-tolerated regimen."
09/01/2001 - "A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients."
07/01/1999 - "Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors."
07/01/1998 - "A phase I trial of 9-aminocamptothecin (9-AC) was performed in children with solid tumors to establish the dose-limiting toxicity (DLT), maximum-tolerated dose (MTD), and the pharmacokinetic profile in children and to document any evidence of activity. "
07/01/1998 - "Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study."
05/01/1999 - "Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia."
12/01/1998 - "Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia."
12/01/1998 - "We utilized this model of human leukemia to investigate the in vivo therapeutic efficacy of the topoisomerase I inhibitor 9-aminocamptothecin (9-AC) given by two different routes. "
04/01/2009 - "Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551."
|3.||Glioblastoma (Glioblastoma Multiforme)
01/01/1998 - "The modified CRM was used in two dose-finding trials of 9-aminocamptothecin in patients with newly diagnosed and recurrent glioblastoma who were taking anticonvulsant medication. "
01/01/2000 - "Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma. "
|4.||Neoplasm Metastasis (Metastasis)
12/01/1995 - "9-Amino-20(S)-camptothecin was effective in the CNS model and in the model of liver metastases. "
06/01/1997 - "A comparison of locoregional depot and systemic preparations of 9-aminocamptothecin for treatment of liver metastases in a rat tumor model: superior antitumor activity of sustained-release preparation."
|5.||Melanoma (Melanoma, Malignant)
|1.||Type I DNA Topoisomerases (Topoisomerase I)
|10.||aniline (aniline hydrobromide)
|1.||Heterologous Transplantation (Xenotransplantation)